Diversify your ETF portfolio for a smoother ride.

The United States-based engineering and construction firms are experiencing a boom in public infrastructure demand fueled by several government initiatives, namely the Infrastructure Investment and Jobs Act (IIJA), CHIPS Act and Inflation Reduction Act (IRA). Reflecting this trend, EMCOR Group, Inc. EME and Quanta Services, Inc. PWR are also gaining due to the ongoing favorable market fundamentals.

AVO and LMNR take different paths in fresh produce, like global scale, tech and diversification versus land, citrus and real estate, to fuel long-term growth.

Freshworks unveils Freddy Agentic AI, a platform that automates complex tasks across support teams - no coding needed.

Broadridge Financial's strong recurring revenue growth, high margins, and consistent EPS gains support, my continued Buy rating, despite the Quant system's Hold. Quant ratings are highly sensitive to small share price changes, making them more useful for value investors seeking optimal entry points. Broadridge's industry leadership, robust backlog, and sector tailwinds (including AI) position it for continued steady growth and productivity gains.

Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion.

Meta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) has filed a lawsuit against Joy Timeline HK Limited, the Hong Kong-based developer behind CrushAI, an app that uses artificial intelligence to generate non-consensual nude and sexually explicit images of individuals by manipulating their photos. Filed in a Hong Kong district court, the lawsuit alleges that the company repeatedly violated Meta's advertising policies by promoting CrushAI across Facebook and Instagram.

QFIN's AI-Plus credit strategy boosts loan volume, trims funding costs and drives a 41% jump in new borrowers.

Peloton's rebound reflects rising subscriptions, tight cost control and refurbished sales. Yet, the hardware sales drag lingers.

Temasek has joined a consortium backed by Microsoft , BlackRock and tech investment company MGX to invest and expand artificial intelligence infrastructure, according to BlackRock's investor day presentation slides on Thursday.

POSCO taps into Australia's mineral wealth with a new R&D lab aimed at boosting its edge in steel and battery tech.

META Platforms stock (NASDAQ: META) has witnessed a substantial increase, spurred by investor enthusiasm over rising user interaction and consistently robust quarterly earnings. So far this year, Meta has gained 16%, significantly outperforming the wider NASDAQ index, which has increased by 2%.

American Airlines (NASDAQ:AAL) shares are currently priced around $11.10, reflecting a 35% decline this year, and positioning itself as a less attractive investment despite its apparently low valuation. A thorough examination of American Airlines' operational performance, financial health, and historical endurance uncovers numerous critical issues that overshadow its reduced price.

EyePoint Pharmaceuticals, Inc.'s Duravyu shows promising Phase 2 results in DME, supporting a slightly risky 'Buy' call ahead of pivotal Phase 3 readouts in 2026. Duravyu's potential for less frequent dosing could offer a key advantage over current market leaders Eylea and Vabysmo. Rapid enrollment in Phase 3 trials and robust safety/efficacy data boost confidence, but competition and market fragmentation remain significant risks.

UBS has reiterated its 'buy' rating on AstraZeneca PLC (LSE:AZN) with a 12-month price target of 14,200p, offering potential upside of just over 30% from the current share price of 10,907p. The focus is on two high-profile drug candidates with contrasting outlooks.

APLE adds a Tampa Hilton asset for $18.8M, tapping into the city's booming demand drivers and strategic growth prospects.

Cooling May inflation boosts prospects for ETFs tied to consumer spending, tech growth, homebuilding and real estate.

RKLB launches its 66th Electron rocket, advancing a major iQPS deal and bolstering its role in satellite deployment.

Garrett Nelson with CFRA is bullish when it comes to Tesla's (TSLA) long-term prospects but plans to "stay on the sidelines" near-term. On the company's robotaxi launch in Austin, Garrett points out the tentative June 22nd launch date as strange, leading him to believe Telsa wants to keep the event "low key.

The National Hurricane Center will experiment with the company's DeepMind program to enhance the work of its expert meteorologists.